RU2000133031A - A method of evaluating the effectiveness of a course of hyperbaric oxygenation - Google Patents

A method of evaluating the effectiveness of a course of hyperbaric oxygenation

Info

Publication number
RU2000133031A
RU2000133031A RU2000133031/14A RU2000133031A RU2000133031A RU 2000133031 A RU2000133031 A RU 2000133031A RU 2000133031/14 A RU2000133031/14 A RU 2000133031/14A RU 2000133031 A RU2000133031 A RU 2000133031A RU 2000133031 A RU2000133031 A RU 2000133031A
Authority
RU
Russia
Prior art keywords
course
hyperbaric oxygenation
interval
effectiveness
hyperbaric
Prior art date
Application number
RU2000133031/14A
Other languages
Russian (ru)
Other versions
RU2192836C2 (en
Inventor
Борис Львович Мультановский
Николай Иванович Максимов
Лев Александрович Лещинский
Original Assignee
Борис Львович Мультановский
Filing date
Publication date
Application filed by Борис Львович Мультановский filed Critical Борис Львович Мультановский
Priority to RU2000133031/14A priority Critical patent/RU2192836C2/en
Priority claimed from RU2000133031/14A external-priority patent/RU2192836C2/en
Application granted granted Critical
Publication of RU2192836C2 publication Critical patent/RU2192836C2/en
Publication of RU2000133031A publication Critical patent/RU2000133031A/en

Links

Claims (1)

Способ оценки эффективности курса гипербарической оксигенации, включающий определение физиологических показателей, отличающийся тем, что в качестве физиологических показателей используют дисперсию интервала QT, при этом до начала курса гипербарической оксигенации и после его окончания у больного проводят электрокардиографию и определяют дисперсию интервала QT, и при значении дисперсии интервала QT после окончания курса гипербарической оксигенации меньшем, чем значение дисперсии интервала QT до проведения курса гипербарической оксигенации, эффект курса гипербарической оксигенации расценивают как удовлетворительный, а при значении дисперсии интервала QT после окончания курса гипербарической оксигенации большем или равном значению дисперсии интервала QT до проведения курса гипербарической оксигенации - как неудовлетворительный.A method for assessing the effectiveness of a course of hyperbaric oxygenation, including the determination of physiological parameters, characterized in that the physiological parameters are used for dispersion of the QT interval, and before the course of hyperbaric oxygenation and after its completion, the patient is electrocardiographed and the dispersion of the QT interval is determined, and the dispersion value the QT interval after the end of the course of hyperbaric oxygenation is less than the variance of the QT interval before the course of hyperbaric oxygen nation, the effect of the course of hyperbaric oxygenation is regarded as satisfactory, and if the dispersion of the QT interval after the end of the course of hyperbaric oxygenation is greater than or equal to the variance of the QT interval before the course of hyperbaric oxygenation is unsatisfactory.
RU2000133031/14A 2000-12-28 2000-12-28 Method for evaluating hyperbaric oxygenation treatment effectiveness RU2192836C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000133031/14A RU2192836C2 (en) 2000-12-28 2000-12-28 Method for evaluating hyperbaric oxygenation treatment effectiveness

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000133031/14A RU2192836C2 (en) 2000-12-28 2000-12-28 Method for evaluating hyperbaric oxygenation treatment effectiveness

Publications (2)

Publication Number Publication Date
RU2192836C2 RU2192836C2 (en) 2002-11-20
RU2000133031A true RU2000133031A (en) 2003-08-10

Family

ID=20244171

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000133031/14A RU2192836C2 (en) 2000-12-28 2000-12-28 Method for evaluating hyperbaric oxygenation treatment effectiveness

Country Status (1)

Country Link
RU (1) RU2192836C2 (en)

Similar Documents

Publication Publication Date Title
JP2003520232A5 (en)
BR9714427A (en) Apparatus and method for noninvasively measuring cardiac output
WO2002024214A3 (en) Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders
EA200501690A1 (en) COMPOSITION INCLUDING PDE4 INHIBITOR AND PDE5 INHIBITOR
ID27576A (en) USE OF CYCOSPORINE IN TREATMENT OF AUTOIMUN DISEASE DISEASES
NO20030295L (en) Use of derivatives of valproic acid and 2-valproic acid amides for the treatment of manners in bipolar disorders
DE60139266D1 (en) METHOD OF PREPARATION AND USE OF TETRAHYDROCURCUMINOIDS FOR THE REGULATION OF THE PHYSIOLOGICAL AND PATHOLOGICAL CASES IN THE SKIN AND SLEW-CELL CELLS
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
RU2000133031A (en) A method of evaluating the effectiveness of a course of hyperbaric oxygenation
JP2005501108A5 (en)
CA2310926A1 (en) A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
DE60108503D1 (en) Blood pressure monitoring and procedures to determine the risk of disease
RU2003133804A (en) METHOD OF AUTOANALGESIA XENON-OXYGEN MIXTURE
WO2001079287A3 (en) Steatosis-modulating factors and uses thereof
EE200300013A (en) Novel bispidine compounds and their use in the treatment of cardiac arrhythmias
RU2002113596A (en) The drug for the treatment and prevention of endometritis and mastitis in cows and the method of its preparation
HK1045983A1 (en) Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders.
何宇茵 Life Is a Struggle
RU2003112897A (en) METHOD FOR PREOPERATIVE SKIN TREATMENT
RU99127900A (en) METHOD FOR MONITORING THE EFFICIENCY OF THERAPY IN HEAVY ARTERIAL HYPERTENSION
RU2000121525A (en) METHOD FOR DETERMINING PHYSICAL PERFORMANCE
RU2000124826A (en) METHOD OF TREATMENT OF PATIENTS WITH TIGHTLY PNEUMONIA
JP2005516073A5 (en)
RU2002110611A (en) A method for evaluating the effectiveness of combined pharmacotherapy and psychotherapy of patients with neuropsychiatric disorders
RU99114105A (en) METHOD FOR DETERMINING AND FORECASTING THE FUNCTIONAL STATE OF THE VISUAL Nerve